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Abstract
Effect of ornithine which is known to inhibit L-arginine uptake via cationic amino acid trans-
port system has been tested, and compared to aminoguanidine, an iNOS inhibitor in lypopolysac-
charide (LPS)-induced endotoxemia in rats. Serum nitrite/nitrate and malondialdehyde (MDA)
level have been measured, and ileal histology has also been examined. Endotoxin increased serum
nitrite/nitrate and MDA levels from 15.7+/- 2.4 micromol/ml and 2.1 +/-0.2 nmol/ml to 23.1 +/-
1.0 micromol/ml and 5.2+/- 0.3 nmol/ml (both P<0.05), respectively. In addition, LPS caused
ileal degeneration. L-ornithine (500 mg/kg) did not improve septic manifestations, i.e., serum
nitrite/nitrate and MDA levels did not differ from those in endotoxemia. Neither does it have
an improving action on ileal histology. However, higher dose of L-ornithine (2,500 mg/kg) low-
ered the increased level of nitrite/nitrate and MDA by LPS. Moreover, it restored ileal histology
from grade 3 (median) to 0 (median) (P<0.05). On the other hand, aminoguanidine (100 mg/kg)
normalized serum nitrite/nitrate and MDA levels but not ileal histology in endotoxemic rats. In
conclusion, high dose of L-ornithine could improve endotoxemic parameters in LPS-treated rats.
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Eﬀect of ornithine which is known to inhibit L-arginine uptake via cationic amino acid transport system has been tested, and compared to aminoguanidine, an iNOS inhibitor in lypopolysaccharide
(LPS)-induced endotoxemia in rats. Serum nitrite/nitrate and malondialdehyde(MDA)level have been measured, and ileal histology has also been examined. Endotoxin increased serum nitrite/
nitrate and MDA levels from 15.7±2.4μmol/ml and 2.1±0.2 nmol/ml to 23.1±1.0μmol/ml and 5.2±
0.3 nmol/ml(both ＜0.05), respectively. In addition, LPS caused ileal degenaration. L-ornithine
(500 mg/kg)did not improve septic manifestations, serum nitrite/nitrate and MDA levels did not diﬀer from those in endotoxemia. Neither does it have an improving action on ileal histology.
However, higher dose of L-ornithine(2,500 mg/kg) lowered the increased level of nitrite/nitrate and MDA by LPS. Moreover, it restored ileal histology from grade 3(median)to 0(median)( ＜
0.05). On the other hand, aminoguanidine(100 mg/kg)normalized serum nitrite/nitrate and MDA levels but not ileal histology in endotoxemic rats. In conclusion, high dose of L-ornithine could improve endotoxemic parameters in LPS-treated rats.
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B acterial lipopolysaccharide(LPS)or endotoxin is an initiator of the septic syndrome that is recognised as a major cause of multiorgan dysfunction syndrome［1］. Endotoxin triggers the release of numer-
ous mediators including nitric oxide and reactive oxygen species (ROS)which activate a variety of pathological mechanisms that culminate in tissue dysfunction and organ failure［2］.
It has been demonstrated that endotoxemia increases circulating level of nitrite/nitrate(NO??, NO??), stable products of NO in various animals as well as human
 
sepsis［3, 4］. Massive NO production which probably accounts for tissue damage in endotoxemia results from the induction of inducible nitric oxide
 
t
 
ynthase(iNOS)
［5］. Therefore, inhibition of NO as well as ROS production seems to be vital in the treatment of septic syndrome.
NO is synthesized from a semiessential aminoacid,
L-arginine and, its analogues have been used as inhibitors of NOS［6］. L-arginine is mainly transported into endothelial cells via cationic aminoacid transport system
(y?). L-lysine and L-ornithine are known
 
d
 
o inhibit this system［7］. Although eﬀect of L-lysine has been tested in ovine endotoxemia［8］, there is no report with regard to ornithine, another chemically-related amino acid in LPS-induce  o endotoxemiain rats. F  o r that reas ,n  e w
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have aimed to investigate if ornithine has any beneﬁcial eﬀects in rat endotoxemia by evaluating levels of serum nitrite/nitrate and malodialdehyde(MDA), indicators of NO and lipid peroxidation respectively. Further,we have examined any eﬀects of the aminoacid on ileal histology.
Materials and Methods
 
The experiments in this study were conducted in adherence to the rules of the local ethic commitee. Female Wistar rats weighing 170-200 g were housed at constant temperature with 12/12 h periods of light and dark exposure. The animals had free access to standard rat chow and water ad libitum during acclimation period of at least 5 days. After fasting over night in the morning at 10 o’clock the rats were randomly divided into 8 groups.
Group 1:Served as control, received intraperitoneal saline(1 ml/200 g, n＝6);
Group 2:Endotoxin(Escherichia coli lipopolysacchar-
ide, 055:B5, 10 mg/kg, i.p., Sigma, St.
Louis, MO, USA, n＝5),
Group 3:I.p. ornithine (500 mg/kg, Sigma, St.
Louis, MO, USA, n＝4),
Group 4:I.p. ornithine(2,500 mg/kg, n＝5),
Group 5:I.p. aminoguanidine(100 mg/kg, n＝5)
Group 6:I.p. ornithine (500 mg/kg) 10 min before endotoxin injection(n＝6).
Group 7:I.p. ornithine(2,500 mg/kg)10 min before endotoxin injection(n＝6).
Group 8:I.p. aminoguanidine (100 mg/kg) 10 min before endotoxin injection(n＝7).
Six hours later, rats anaesthetized with intramuscular ketamine(50 mg/kg)and the blood was taken by cardiac puncture for nitrite/nitrate levels. In order to evaluate the endotoxin-associated ileal injury, tissue samples were harvested through a midline incision, and ﬁxed in 10 formaldehyde.
/
In biological ﬂuids NO is very rapidly deactivated by oxidation to nitrite and nitrate. After collecting the blood samples by cardiac puncture, we detected NO via nitrite/
nitrate. Nitrate was reduced to nitrite by NADPH in the presence of nitrate reductase and the formed nitrite was put to react with sulphanilamide and N-(1-naphtyl)-
ethylenediamine to give a red-violet diazo dye. The diazo dye measured on the basis of its absorbance in the visible range at 550 nm.
The levels of
 
serum lipid peroxidation products as thiobarbituric acid
(TBA)-malondialdehyde(MDA)adducts were measured spectrophotometrically by the method described by Yagi
［9］. The ﬁnal results were expressed as nmol of MDA formed per mililiter of serum.
The ileal specimens were ﬁxed in 10  form-
aldehyde. Hematoxylin and eosin-stained slides were prepared by using standard methods. Intestinal mucosal damage was graded on a 6-tiered scale as deﬁned by Chiu et al.［10］in a minimum of 20 seperate locations on each sections. Brieﬂy, mucosal damage was graded from 0 to 5 according to the following criteria:
Grade 0:Normal mucosal villi Grade 1:Development of subepithelial space Grade 2:Extension of the subepithelial space with moderate lifting of the epithelial layer from the lamina propria Grade 3:Massive epithelial lifting down the side of the villi Grade 4:Denuded villi with lamina propria and dilated capillaries exposed Grade 5:Digestion and disintegration of lamina pro-
pria;hemorrhage and ulceration Values are given as mean±S.E.M., or median and quartiles. Statistical diﬀerences for serum nitrite/nitrate and MDA values were evaluated using one way of ANOVA followed Bonferroni post hoc test. Comparison for intestinal injury scores was analyzed using Kruskall-Wallis variance analy-
sis followed by Dunn test. P values less than 0.05 were considered signiﬁcant.
Results
/ No animals died during the experimentation. As shown in Table 1,
serum nitrite/nitrate level was found to be increased in endotoxemic group(15.72±2.43μmol/l vs. 23.10±1.0
μmol/l, P＜0.05). While treatment of ornithine (500 mg/kg)failed to prevent the ability of LPS to elevate serum nitrite/nitrate level, higher dose of ornithine(2,500 mg/kg) markedly decreased that level (P＜0.05).
Furthermore, aminoguanidine (100 mg/kg) signiﬁcantly lowered nitrite/nitrate level(P＜0.05).
In LPS-injected group the level of serum malondialdehyde(MDA)was 5.20±
0.30 nmol/ml, whereas it was 2.12±0.21 nmol/ml in
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Table 1  Serum nitrite/nitrate and malondialdehyde(MDA)levels in all groups.
Group  Nitrite＋Nitrate(mmol/ml) MDA(nmol/ml)
Control(n＝6) 15.70± 2.40  2.12±0.21 LPS (n＝8) 23.10± 1.04? 5.20±0.30?
Ornithine(500 mg/kg, n＝4) 8.67± 2.62  1.24±0.11 Ornithine(2,500 mg/kg, n＝5) 8.10± 0.43  1.16±0.05 Aminoguanidine(100 mg/kg, n＝5) 14.20± 0.37  1.04±0.24 LPS＋Ornithine(500 mg/kg, n＝6) 21.00± 2.90  4.10±0.73 LPS＋Ornithine(2,500 mg/kg, n＝6) 17.50±0.45?? 3.05±0.13??
LPS＋Aminoguanidine(100 mg/kg, n＝7) 13.10± 0.49?? 1.50±0.13??
Data are expressed as mean±S.E.M.?, Diﬀerent from control;??, Diﬀerent from LPS-treated group. Statistical diﬀerences were evaluated using one way of ANOVA followed Bonferroni post hoc test.
A  C
 
B  D 
Fig.1  Photomicrographs of small intestine segments (H&E×200).
A, Control group showing normal histology;B, LPS only group showing massive epithelial lifting down the sides of villi with a few denuded tips;C, Ornithine(2,500 mg/kg)reduced the LPS induced intestinal injury(P＜0.05);D, Aminoguanidine(100 mg/kg)did not improve ileal damage by LPS administration. Bars indicate 100μm
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control which is statistically diﬀerent (P＜0.001). In ornithine alone injected groups, the levels of MDA were 1.24±0.11 nmol/ml and 1.16±0.05 at the doses of 500 mg/kg and 2,500 mg/kg, respectively. In the serum from the rats given LPS and 500 mg/kg ornithine MDA levels were 4.10±0.73 nmol/ml which was not signiﬁcantly diﬀerent from LPS-injected group.However,
at the dose of 2,500 mg/kg, ornithine signiﬁcantly de-
creased MDA level from 5.20±0.30 nmol/ml to 3.10±
0.13 (P＜0.01, Table 1). Similarly aminoguanidine lowered both nitrite/nitrate and MDA levels in endotox-
emic rats (Table 1).
Small intestine of the rats was assessed for tissue damage by histologic examination. As shown in Fig. 1B, endotoxemia caused signiﬁcant tissue damage. These changes varied from denuded villi with exposed dilated capillaries to signiﬁcant architectural distortion, lamina propria disintegration,
ulceration and hemorrhage. The histopathologic scores of control and ornithine groups(500 mg/kg and 2,500 mg/
kg)were signiﬁcantly smaller than LPS group(Fig. 2).
LPS plus ornithine(500 mg/kg)did not reduce the LPS induced intestinal injury. There was no statistical signiﬁcant diﬀerence between the scores of LPS and LPS plus ornithine (500 mg/kg) group (Fig. 2). However,
2,500 mg/kg ornithine normalized the intestinal damage by LPS (Fig. 1C). The Chui scores of this group were
 
shown in Fig. 2. However, aminoguanidine(100 mg/kg)
did not prevent LPS-induced ileal injury(Fig. 1D, Fig.
2).
Discussion
 
Selective inhibition of iNOS which is induced by bacterial LPS is of value in the treatment of septic or endotoxemic states as over-produced NO has deleterious eﬀects on tissue histology［11, 12］. This can be achived by some spesiﬁc iNOS inhibitors such as N-(1-
iminoethyl)-L-lysine(L-NIL)and 1,400 W or by some nonspesiﬁc inhibitors of iNOS namely aminoguanidine
［13-15］. However, it has been reported that large doses of non-selective NOS inhibitors may increase mortality,
and the mechanism underlying this eﬀect is not clear but might include impaired tissue perfusion due to excessive vasoconstriction, excessive suppression of cardiac contractility or inhibition of‘physiological’NO, which might be exerting cytoprotective eﬀects［11, 12］.
On the other hand, uptake of L-arginine has been proposed to be rate limiting under certain conditions for NO production［16］. These conditions most probably involve septic and endotoxemic states since iNOS needs further L-arginine after consuming up the intracellular store of the aminoacid to generate NO with a massive amount. Inhibition of the cationic aminoacid transport
 
Fig.2  Histopathologic scores of the bowel specimens obtained from the study groups. Treatment of L-ornithine (2,500 mg/kg)but not aminoguanidine(100 mg/kg)decreased ileal injury score by LPS administration. ?, the diﬀerence from control;?, from LPS-administrated group. Comparison for intestinal injury scores was analyzed using Kruskall-Wallis variance analysis followed by Dunn test. Results are presented median and quartiles. The value of 95% indicates the quartiles and the rest is 5%. P values less than 0.05 were considered signiﬁcant.
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system with other chemically-related aminoacids such as L-lysine or L-ornithine may take an advantage by restrict-
ing the extra supply of L-arginine in endotoxemic condi-
tion but not the physiological formation of NO by the constitutive NOSs because intracellular L-arginine store is suﬃcient for those enzyme-catalysed NO production.
Indeed, it has been demonstrated that L-arginine uptake is inhibited by L-lysine, L-homoarginine and L-ornithine
［17, 18］. It has been suggested that constitutive NO formation be unaﬀected in sepsis or related states as it is physiologically necessary for the regulation hemodynamic parameters［11, 19］. One attempt has been made in ovine endotoxemia with L-lysine. However, the amino acid failed to restore the refractory hypotension but did L-NAME, a non-speciﬁc NOS inhibitor［8］. Neither did L-lysine change serum nitrite/nitrate level. Conversely,
in rat endotoxemic model L-lysine administration caused the inhibition of NO production by iNOS but not by constitutive NOS (cNOS)［20］. In the present study,
however, we have tried another inhibitor aminoacid,
ornithine for the y?system. Smaller dose of ornithine had no improving eﬀects on either ileal histology or serum nitrite/nitrate level as well as lipid peroxidation in en-
dotoxemic condition. One reason for the failure seems to be due to the insuﬃcient amount of L-ornithine given.
Accordingly, we examined higher dose (2,500 mg/kg),
and it restored endotoxin-induced ileal damage. Likewise,
the dose dramatically lowered both nitrite/nitrate and MDA levels, supporting the restorative eﬀects of the aminoacid. On the other hand L-ornithine signiﬁcantly decreased LPS-induced nitrite accumulation in murine bone marrow derived macrophages［21］, conﬁrming the results of our study. Apart from the relationship of L-ornithine with L-arginine:NO pathway, the aminoacid is also a substrate for poliamine synthesis. It is not known whether poliamine synthesis is increased with ornithine treatment, and possible increased level of poliamines have any eﬀects on the parameters in this study. It has been reported that NO can inhibit ornithine decarboxylase which is the initial and rate limiting step in poliamine synthesis that is necessary for cell growth in mammals［22］.
On the other hand,marginally-spesiﬁc iNOS inhibitor,
aminoguanidine did not improve ileal damage, although it dramatically diminished nitrite/nitrate overproduction and MDA levels in the study. This may reﬂect that restora-
tive eﬀect of ornithine might not be parellel with the decreased amount of nitrite/nitrate and MDA, or it has
 
improving eﬀect via diﬀerent mode of action, or aminoguanidine itself has deleterious eﬀect on the ileal histology although it substantially lowered both MDA and nitrite/nitrate levels.
In conclusion, L-arginine uptake which is the rate limiting for NO biosynthesis can be inhibited by high dose of L-ornithine. Therefore, it seems to be a beneﬁcial agent which can reduce noxious NO formation that could mediate tissue damage in the rat endotoxemia.
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